Amicus Therapeutics Inc is a leading biotechnology company based in Charlotte, NC, specializing in the development of advanced therapies for rare genetic diseases. With a strong commitment to patient advocacy and access to medicines, Amicus leverages innovative technology platforms to create treatments for devastating rare diseases.
Driven by a belief in the power of scientific innovation, Amicus Therapeutics is dedicated to changing the lives of patients with rare metabolic diseases. Through their pipeline of programs and clinical trials, they aim to provide hope and improved quality of life for individuals living with these challenging conditions.
Generated from the website